Filing Details
- Accession Number:
- 0001209191-14-073237
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-04 19:55:28
- Reporting Period:
- 2014-12-03
- Filing Date:
- 2014-12-04
- Accepted Time:
- 2014-12-04 19:55:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1333170 | Nxstage Medical Inc. | NXTM | Electromedical & Electrotherapeutic Apparatus (3845) | 043454702 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1382096 | S. Robert Brown | C/O Nxstage Medical, Inc. 350 Merrimack Street Lawrence MA 01843 | President, Kidney Care | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-12-03 | 300 | $14.44 | 47,928 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-12-03 | 300 | $17.48 | 47,628 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2014-12-03 | 300 | $0.00 | 300 | $14.44 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2008-01-07 | 2014-12-06 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2014.
- This represents the weighted average price for shares sold in multiple transactions at prices ranging from $17.42 to $17.53, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request.